52w high/low | ₹5.93 / ₹3.03 |
P/E ratio | -191.5 |
Dividend | 0 |
ROE | 3.93 |
ROCE | -2.28 |
Face value | 10 |
Book value | ₹-0.89Cr |
Market capital | ₹58.04Cr |
What is shareholding pattern? Who are shareholders?
What is a cash flow statement?
What is a balance sheet?
What is a profit and loss statement?
What are dividends?
What are bonuses?
Transgene Biotek was incorporated as a private limited company in Mar. '90 and was converted into a public limited company in Nov. '90. The company is engaged in the research and development and manufacture of various medical reagents, both chemical and immuno-diagnostic reagents for the qualitative and quantitative estimation of bio-chemical parameters and diagnosis of diseases respectively. Transgene Biotek's products are exported to Africa, Russia, China, Malaysia and the Phillipines. The company chalked out a new project for setting up a manufacturing facility at a cost of Rs. 30 crore at the Anrich Industrial Area,Bollaram. TBL is working of four new plants:Oral deliver of proteins and peptides:DNA vaccines:fusion proteins and bio therapeutics.